Related Experiment Videos

Serum amyloid A and P protein genes in familial Mediterranean fever

M Shohat1, T Shohat, J I Rotter

  • 1Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA 90048.

Genomics
|September 1, 1990
PubMed

Insights

This study investigated serum amyloid A (SAA) and P (APCS) genes in familial Mediterranean fever (MEF). Researchers found no evidence linking these genes to MEF or MEF-amyloidosis in Armenian and Jewish populations.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Familial Mediterranean fever (MEF) is a genetic autoinflammatory disorder.
  • Previous studies suggested potential roles for serum amyloid A (SAA) and apolipoprotein C (APCS) genes in MEF pathogenesis.
  • Amyloidosis is a common complication of MEF, leading to organ damage.

Purpose of the Study:

  • To investigate the potential involvement of SAA and APCS genes in the development of MEF and MEF-associated amyloidosis.
  • To analyze genetic variations and linkage in Armenian and Jewish populations with MEF.

Main Methods:

  • Candidate gene approach was utilized.
  • Genetic analysis was performed on 17 informative families and 8 MEF patients with amyloidosis.
  • Linkage analysis and allele frequency comparisons were conducted for SAA and APCS genes.

Main Results:

  • No MEF-associated polymorphisms were identified in SAA or APCS genes in 41 MEF patients.
  • Tight linkage between SAA and MEF was ruled out (lod score = -2.16).
  • APCS allele frequencies were similar in MEF-amyloidosis patients and controls, excluding close genetic linkage (lod score = -2.2).

Conclusions:

  • The study provides no evidence for the involvement of SAA and APCS genes in MEF or MEF-amyloidosis in the studied populations.
  • These findings suggest that SAA and APCS are unlikely to be major susceptibility genes for MEF.
  • Further research may be needed to identify other genetic factors contributing to MEF and its complications.

Related Concept Videos